Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-059054
Filing Date
2020-11-18
Accepted
2020-11-18 16:10:55
Documents
1
Period of Report
2020-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3718
  Complete submission text file 0001209191-20-059054.txt   5139
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Aker Christopher Ray (Reporting) CIK: 0001762611 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 201325050